Search

Emily Ann Stein

from Minneapolis, MN
Age ~47
Get Report
Also known as:
Emily A Stein, Emily L Stein, Stein Emily
Related to:
Jaqueline BarberenaPeggy Stein, 64Reed Stein, 34
Connected to:
Amy K Stein, 38Benay W Stein, 71Bland A Stein, 90Brigitte M Stein, 33Cathleen A Stein, 62Chaya Stein, 45Darla J Stein, 71Daryl L Stein, 74Debra I Stein, 64Dinah Stein, 73

Emily Stein Phones & Addresses

  • Minneapolis, MN
  • Denver, CO
  • Redwood City, CA
  • San Leandro, CA
  • San Francisco, CA
  • Swisher, IA
  • Iowa City, IA
  • Berkeley, CA

Work

Company: University of california, berkeley Address: 1125 Jackson St, Berkeley, CA 94706 Phones: (510) 526-8505 Position: Faculty/staff-microbial pathogenesis Industries: Colleges, Universities, and Professional Schools

Professional Records

Lawyers & Attorneys

Emily Stein Photo 1

Emily Stein - Lawyer

View page
ISLN:
923017582
Admitted:
2007

Medicine Doctors

Emily Stein Photo 2

Emily M. Stein

View page
Specialties:
Endocrinology, Diabetes & Metabolism
Work:
Columbia University Endocrinology
630 W 168 St STE 864, New York, NY 10032
(212) 305-2663 (phone), (212) 342-0501 (fax)

Metabolism Bone Disease Program At Columbia University Medical Center
180 Ft Washington Ave STE 904, New York, NY 10032
(212) 305-2663 (phone), (212) 342-0501 (fax)
Education:
Medical School
Albert Einstein College of Medicine at Yeshiva University
Graduated: 2001
Languages:
English
Spanish
Description:
Dr. Stein graduated from the Albert Einstein College of Medicine at Yeshiva University in 2001. She works in New York, NY and 1 other location and specializes in Endocrinology, Diabetes & Metabolism. Dr. Stein is affiliated with New York Presbyterian Hospital Columbia University Medical Center.
Emily Stein Photo 3

Emily Sara Stein

View page
Specialties:
Psychiatry
Education:
State University of New York Downstate (2003)
Emily Stein Photo 4

Emily Fanya Stein

View page
Specialties:
Psychiatry
Education:
University of California at Irvine (2006)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Emily Stein
Faculty/staff-microbial Pathogenesis
University of California, Berkeley
Colleges, Universities, and Professional Scho...
1125 Jackson St, Berkeley, CA 94706
Ms. Emily Stein
Business Development
ActionCOACH Business Coaching
Go2Advisor Network LLC. Premier Advisory Group. ActionCOACH Team Empowerment. Go2 Business Solutions
Business Consultants
390 Union Blvd STE 310, Lakewood, CO 80228
(720) 981-0926
Emily Stein
Faculty/staff-microbial Pathogenesis
University of California, Berkeley
Colleges, Universities, and Professional Scho...
1125 Jackson St, Berkeley, CA 94706
Emily Stein
President
Rejuvenis Medical Clinic
Medical Doctor's Office
478 E Santa Clara St, San Jose, CA 95112
(408) 924-0339
Emily Ann Stein
M
Bugsy Solar, LLC
26454 Taffee Ame, Los Altos, CA 94022
963 Helen Ave, San Leandro, CA 94577
Emily Stein
Business Development
ActionCOACH Business Coaching
Business Consultants
390 Un Blvd STE 310, Denver, CO 80228
(720) 981-0926
Emily Stein
Faculty/staff-microbial Pathogenesis
University of California, Berkeley
1125 Jackson St, Berkeley, CA 94706
(510) 526-8505, (510) 527-9934
Emily Fanya Stein
Emily Stein MD
Psychiatrist
401 Parnassus Ave, San Francisco, CA 94143
(415) 476-7577
Emily Stein
Officer, Principal
Enclusa Therapeutics LLC
Commercial Physical Research · Commercial Physical Research, Nsk
555 Bryant St, Palo Alto, CA 94301
3475 Edison Way, Menlo Park, CA 94025

Publications

Us Patents

Methods And Devices For Denervation

View page
US Patent:
20110184337, Jul 28, 2011
Filed:
Jan 26, 2011
Appl. No.:
13/014702
Inventors:
Michael A. EVANS - Palo Alto CA, US
Emily A. STEIN - Redwood City CA, US
International Classification:
A61M 37/00
A61M 25/00
A61M 25/10
US Classification:
604 22, 604523, 60410302, 604506
Abstract:
Various delivery devices are described to deliver an agent locally to the renal nerves. The delivery devices are positioned in the renal artery and penetrate into the wall of the renal artery to deliver the agent to the renal nerves. The delivery devices may be used to deliver the agent according to longitudinal position, radial position, and depth of the renal nerves relative to the renal artery. In addition, various methods are described to denervate, modulate, or otherwise affect the renal nerves and other neural tissue. Also, various agents are described to denerve, modulate, or otherwise affect the renal nerves and other neural tissue.

Agents And Methods For Denervation

View page
US Patent:
20120108517, May 3, 2012
Filed:
Apr 28, 2011
Appl. No.:
13/096446
Inventors:
Michael A. EVANS - Palo Alto CA, US
Emily A. STEIN - Redwood City CA, US
International Classification:
A61K 31/7028
A61P 43/00
A61K 38/02
A61K 31/366
A61K 31/7048
A61K 31/40
US Classification:
514 177, 514 23, 514 26, 514423, 514453
Abstract:
Various agents are described to denerve, modulate, or otherwise affect the renal nerves and other neural tissue. Also, various delivery devices are described to deliver an agent locally to the renal nerves. The delivery devices are positioned in the renal artery and penetrate into the wall of the renal artery to deliver the agent to the renal nerves. The delivery devices may be used to deliver the agent according to longitudinal position, radial position, and depth of the renal nerves relative to the renal artery. In addition, various methods are described to denervate, modulate, or otherwise affect the renal nerves and other neural tissue.

Devices For Detection Of Analytes

View page
US Patent:
20130052653, Feb 28, 2013
Filed:
Nov 24, 2010
Appl. No.:
13/511364
Inventors:
Emily A. Stein - Redwood City CA, US
Michael A. Evans - Palo Alto CA, US
Assignee:
ARGOS, INC. - San Francisco CA
International Classification:
G01N 33/569
C07K 17/02
G01N 33/53
US Classification:
435 71, 436501, 5303911, 530329
Abstract:
The invention provides “molecular nets” which may be used in diagnostic and other applications to detect analytes in a sample. A molecular net is a branched pseudorandom copolymer comprising two broad classes of subunits: capture agents and linking agents. The subunits self-assemble to form a structure capable of binding to predetermined targets. The binding can then be detected.

Cardiac Glycosides For Treating Autoimmune Disease

View page
US Patent:
20140011755, Jan 9, 2014
Filed:
Dec 13, 2011
Appl. No.:
13/992182
Inventors:
Emily A. Stein - Redwood City CA, US
William H. Robinson - Palo Alto CA, US
Ricardo T. Paniagua - Dallas TX, US
Assignee:
Department of Veterans Affairs - Washington DC
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61K 31/7048
A61K 31/585
US Classification:
514 26, 514175
Abstract:
The invention provides methods for treating inflammatory and autoimmune diseases by administering to the subject an effective amount of a cardiac glycoside, where the dose is effective to suppress or prevent initiation, progression, or relapses of the disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject determined to have rheumatoid arthritis or systemic lupus, or a pre-clinical disease state thereof, an effective amount of a cardiac glycoside, to suppress or prevent activity of the disease. In other embodiments, the methods of the invention comprise administering to a subject determined to have insufficient endogenous cardiac glycosides, an effective amount as a supplement to counteract the effects of cardiac glycoside deficiency.

Agents And Methods For Denervation

View page
US Patent:
20110182912, Jul 28, 2011
Filed:
Jan 26, 2011
Appl. No.:
13/014700
Inventors:
Michael A. EVANS - Palo Alto CA, US
Emily A. STEIN - Redwood City CA, US
International Classification:
A61K 39/395
A61K 31/7048
A61K 31/40
A61K 31/519
A61K 38/16
A61K 38/04
A61K 31/277
A61K 31/55
A61K 31/455
A61K 31/554
A61P 25/00
US Classification:
4241581, 514 26, 514423, 514257, 514 177, 514523, 51421114, 514356, 51421105
Abstract:
Various agents are described to denerve, modulate, or otherwise affect the renal nerves and other neural tissue. Also, various delivery devices are described to deliver an agent locally to the renal nerves. The delivery devices are positioned in the renal artery and penetrate into the wall of the renal artery to deliver the agent to the renal nerves. The delivery devices may be used to deliver the agent according to longitudinal position, radial position, and depth of the renal nerves relative to the renal artery. In addition, various methods are described to denervate, modulate, or otherwise affect the renal nerves and other neural tissue.

Methods, Agents, And Devices For Local Neuromodulation Of Autonomic Nerves

View page
US Patent:
20220370345, Nov 24, 2022
Filed:
Feb 11, 2022
Appl. No.:
17/669778
Inventors:
- Los Gatos CA, US
Emily Stein - San Jose CA, US
International Classification:
A61K 9/00
Abstract:
Methods, agents, and devices to treat medical conditions through local chemical neuromodulation of the autonomic nervous system are described. Drug formulations may be injected at or near ganglia, nerve plexi, ganglionated plexi, and nerves to treat different diseases. Target sites for the treatment of cardiac and other disease conditions may include extrinsic stellate (cervicothoracic) and cervical ganglia of the sympathetic chain, and intrinsic cardiac nerves and ganglionated plexi innervating the myocardium.

Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System

View page
US Patent:
20220280497, Sep 8, 2022
Filed:
Oct 20, 2021
Appl. No.:
17/506354
Inventors:
- Los Altos Hills CA, US
Emily Stein - San Jose CA, US
International Classification:
A61K 31/455
A61P 29/00
A61K 9/00
A61L 27/52
Abstract:
Methods of use, formulations, and devices for delivering therapeutic drugs locally to the region of the spleen are described herein. A method for treating sepsis and other inflammatory disease conditions can include inserting a drug delivery system inside the body, advancing the device to the spleen through the splenic artery, splenic vein or other blood vessel adjacent to the splenic nerves, or within a ligament associated with the spleen, such as the splenorenal or gastrosplenic ligaments.

Biochemical Energy Conversion Cell

View page
US Patent:
20230080892, Mar 16, 2023
Filed:
Oct 31, 2022
Appl. No.:
18/051139
Inventors:
- Los Altos Hills CA, US
Emily A. Stein - San Leandro CA, US
International Classification:
H01G 9/20
H01L 51/00
Abstract:
Presented herein is a voltaic cell containing light harvesting antennae or other biologically-based electron generating structures optionally in a microbial population, an electron siphon population having electron conductive properties with individual siphons configured to accept electrons from the light harvesting antennae and transport the electrons to a current collector, an optional light directing system (e.g., a mirror), and a regulator having sensing and regulatory feedback properties for the conversion of photobiochemical energy and biochemical energy to electricity. Also presented herein is a voltaic cell having electricity-generating abilities in the absence of light. Also presented herein is the use of the voltaic cell in a solar panel.

Amazon

Young People's Transitions From Care To Adulthood: International Research And Practice (Child Welfare Outcomes)

Young People's Transitions from Care to Adulthood: International Research and Practice (Child Welfare Outcomes)

View page

The transition from care into adulthood is a difficult step for any young person, but young people leaving care have a high risk of social exclusion, both in terms of material disadvantage and marginalization. In "Young People's Transitions from Care to Adulthood" leading academics gather together t...
Binding

Paperback

Pages

320

Publisher

Jessica Kingsley

ISBN #

1843106108

EAN Code

9781843106104

ISBN #

6

Control profile
Emily Ann Stein from Minneapolis, MN, age ~47 Get Report